Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (21-30 of 466) with videos related to

Pageof 47
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and InstructiveGregory J Dore, Benjamin Cowie
Nature Reviews. Gastroenterology & Hepatology|January 6, 2021
Author Correction: Hepatitis C virus elimination: laying the foundation for achieving 2030 targetsGregory J Dore, Sahar Bajis
Nature Reviews. Gastroenterology & Hepatology|December 1, 2020
Hepatitis C virus elimination: laying the foundation for achieving 2030 targetsGregory J Dore, Sahar Bajis
Nature Reviews. Gastroenterology & Hepatology|May 1, 2020
Universal screening for hepatitis C virus infection should be linked to universal treatment accessGregory J Dore, Gail V Matthews
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2015
Hepatitis C virus therapeutic development: in pursuit of "perfectovir"Gregory J Dore, Jordan J Feld
Lancet (London, England)|August 8, 2006
HAART's first decade: success brings further challengesGregory J Dore, David A Cooper
AIDS (London, England)|April 7, 2007
Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'Gail V Matthews, Gregory J Dore
Journal of Hepatology|February 12, 2025
Metabolic dysfunction-associated steatotic liver disease a multisystem disease: Assessing the cost effectiveness of pharmacotherapiesChristopher D Byrne, Gregory J Dore
The New England Journal of Medicine|July 6, 2012
The perpetual challenge of infectious diseasesBenjamin C Cowie, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2025
Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject DrugsJoanne M Carson, Gregory J Dore
Pageof 47

Showing results (21-30 of 466) with videos related to

Sort By:
Pageof 47
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and InstructiveGregory J Dore, Benjamin Cowie
Nature Reviews. Gastroenterology & Hepatology|January 6, 2021
Author Correction: Hepatitis C virus elimination: laying the foundation for achieving 2030 targetsGregory J Dore, Sahar Bajis
Nature Reviews. Gastroenterology & Hepatology|December 1, 2020
Hepatitis C virus elimination: laying the foundation for achieving 2030 targetsGregory J Dore, Sahar Bajis
Nature Reviews. Gastroenterology & Hepatology|May 1, 2020
Universal screening for hepatitis C virus infection should be linked to universal treatment accessGregory J Dore, Gail V Matthews
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2015
Hepatitis C virus therapeutic development: in pursuit of "perfectovir"Gregory J Dore, Jordan J Feld
Lancet (London, England)|August 8, 2006
HAART's first decade: success brings further challengesGregory J Dore, David A Cooper
AIDS (London, England)|April 7, 2007
Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'Gail V Matthews, Gregory J Dore
Journal of Hepatology|February 12, 2025
Metabolic dysfunction-associated steatotic liver disease a multisystem disease: Assessing the cost effectiveness of pharmacotherapiesChristopher D Byrne, Gregory J Dore
The New England Journal of Medicine|July 6, 2012
The perpetual challenge of infectious diseasesBenjamin C Cowie, Gregory J Dore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2025
Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject DrugsJoanne M Carson, Gregory J Dore
Pageof 47